Increasing the Sensitivity of Cytogenetic Analysis of Hematologic Malignancies Through Cell Enrichment
In hematologic cancers, including B cell lymphomas and multiple myeloma, malignant and non-malignant cells are mixed in the bone marrow or peripheral blood at variable frequencies. Enrichment of lymphoid cells prior to further analysis using Fluorescence In Situ Hybridization (FISH) can enhance the sensitivity of this technique by increasing the presence of malignant cells. This improves the resolution of FISH in detecting chromosomal abnormalities in patient samples, particularly in cases where disease burden is low.
This webinar is sponsored by STEMCELL Technologies and Molecular at Abbott.
Publish Date:
February 27, 2021
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Automate Cell Isolation with the RoboSep™-S Cell Separation Instrument
Publish Date: March 31, 2014 -
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016
Explore Our Products
-
EasySep™ HLA Chimerism Whole Blood CD19 Positive Selection Kit
Immunomagnetic positive selection of human CD19+ cells from whole blood
